[go: up one dir, main page]

GB202211203D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB202211203D0
GB202211203D0 GBGB2211203.1A GB202211203A GB202211203D0 GB 202211203 D0 GB202211203 D0 GB 202211203D0 GB 202211203 A GB202211203 A GB 202211203A GB 202211203 D0 GB202211203 D0 GB 202211203D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2211203.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leeds
University of Leeds Innovations Ltd
Original Assignee
University of Leeds
University of Leeds Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leeds, University of Leeds Innovations Ltd filed Critical University of Leeds
Priority to GBGB2211203.1A priority Critical patent/GB202211203D0/en
Publication of GB202211203D0 publication Critical patent/GB202211203D0/en
Priority to AU2023318246A priority patent/AU2023318246A1/en
Priority to CN202380051112.7A priority patent/CN119486602A/en
Priority to PCT/GB2023/052017 priority patent/WO2024028584A1/en
Priority to EP23755144.5A priority patent/EP4565069A1/en
Ceased legal-status Critical Current

Links

GBGB2211203.1A 2022-08-01 2022-08-01 Formulation Ceased GB202211203D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2211203.1A GB202211203D0 (en) 2022-08-01 2022-08-01 Formulation
AU2023318246A AU2023318246A1 (en) 2022-08-01 2023-07-31 Formulation
CN202380051112.7A CN119486602A (en) 2022-08-01 2023-07-31 Preparations
PCT/GB2023/052017 WO2024028584A1 (en) 2022-08-01 2023-07-31 Formulation
EP23755144.5A EP4565069A1 (en) 2022-08-01 2023-07-31 Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2211203.1A GB202211203D0 (en) 2022-08-01 2022-08-01 Formulation

Publications (1)

Publication Number Publication Date
GB202211203D0 true GB202211203D0 (en) 2022-09-14

Family

ID=84540661

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2211203.1A Ceased GB202211203D0 (en) 2022-08-01 2022-08-01 Formulation

Country Status (1)

Country Link
GB (1) GB202211203D0 (en)

Similar Documents

Publication Publication Date Title
IL319149A (en) Upadacitinib formulation
GB202007546D0 (en) Formulation
IL307849A (en) Sotorasib formulation
GB202318884D0 (en) Formulation
GB202316857D0 (en) Cannabinoid-based formulation
GB202312814D0 (en) Formulation
GB202312220D0 (en) Formulation
GB202311622D0 (en) Formulation
GB202311439D0 (en) Formulation
IL317857A (en) Orellanine formulation
GB202308224D0 (en) Formulation
GB202306990D0 (en) Cannabinoid-based formulation
GB202306995D0 (en) Cannabinoid-based formulation
GB202307002D0 (en) Cannabinoid-based formulation
GB202307003D0 (en) Cannabinoid-based formulation
GB202303663D0 (en) Aerosolisable formulation
GB202218160D0 (en) Formulation
GB202217857D0 (en) Formulation
GB202217267D0 (en) Aerosolisable formulation
GB202217148D0 (en) Formulation
GB202216335D0 (en) Formulation
GB202213663D0 (en) Aerosolisable formulation
GB202211203D0 (en) Formulation
GB202209298D0 (en) Aerosolisable formulation
GB202211231D0 (en) Novel formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)